Fiserv Inc. (FISV)
| Sector: | Information Technology |
| Super Investor Stats: | |
| Ownership count: | 10 |
| Ownership rank: | 39 |
| % of all portfolios: | 0.153% |
| Hold Price * : | $64.89 |
| History | Portfolio Manager | Activity ▼ | Share change | % change to portfolio | |
| Q4  2025 | |||||
| ≡ | Mairs & Power Funds | Reduce 6.10% | 106,681 | 0.07 | |
| ≡ | Francois Rochon - Giverny Capital | Sell 100.00% | 651,257 | 2.85 | |
| ≡ | David Tepper - Appaloosa Management | Sell 100.00% | 925,000 | 1.62 | |
| ≡ | Norbert Lou - Punch Card Management | Sell 100.00% | 37,000 | 1.48 | |
| ≡ | Robert Olstein - Olstein Capital Management | Sell 100.00% | 58,000 | 1.41 | |
| ≡ | David Katz - Matrix Asset Advisors | Sell 100.00% | 78,306 | 0.94 | |
| ≡ | Torray Funds | Sell 100.00% | 45,561 | 0.82 | |
| Q3  2025 | |||||
| ≡ | Torray Funds | Reduce 1.90% | 882 | 0.02 | |
| ≡ | Leon Cooperman | Sell 100.00% | 390,000 | 2.36 | |
| Q2  2025 | |||||
| ≡ | Dodge & Cox Funds | Reduce 2.85% | 870,955 | 0.08 | |
| ≡ | Bill Nygren - Oakmark Funds | Reduce 5.66% | 319,849 | 0.09 | |
| ≡ | Torray Funds | Reduce 61.01% | 72,687 | 1.82 | |
| ≡ | John Armitage - Egerton Capital | Sell 100.00% | 2,381,496 | 6.07 | |
| Q1  2025 | |||||
| ≡ | Francois Rochon - Giverny Capital | Reduce 0.10% | 621 | 0.01 | |
| ≡ | Dodge & Cox Funds | Reduce 4.98% | 1,601,904 | 0.20 | |
| ≡ | Torray Funds | Reduce 5.06% | 6,355 | 0.21 | |
| ≡ | Mairs & Power Funds | Reduce 8.22% | 153,852 | 0.35 | |
| ≡ | Bill Nygren - Oakmark Funds | Reduce 37.58% | 3,402,551 | 1.26 | |
| ≡ | David Katz - Matrix Asset Advisors | Sell 100.00% | 31,264 | 0.70 | |
| ≡ | Vulcan Value Partners | Sell 100.00% | 146,008 | 0.50 | |
| ≡ | Samantha McLemore - Patient Capital Management | Sell 100.00% | 10,042 | 0.10 | |
| Q4  2024 | |||||
| ≡ | Mairs & Power Funds | Reduce 1.17% | 22,227 | 0.04 | |
| ≡ | Dodge & Cox Funds | Reduce 1.62% | 531,372 | 0.06 | |
| ≡ | John Armitage - Egerton Capital | Reduce 9.85% | 253,886 | 0.60 | |
| ≡ | David Katz - Matrix Asset Advisors | Reduce 13.09% | 4,707 | 0.11 | |
| ≡ | Torray Funds | Reduce 17.14% | 25,965 | 0.77 | |
| ≡ | Leon Cooperman | Reduce 20.83% | 100,000 | 0.78 | |
| ≡ | Bill Nygren - Oakmark Funds | Reduce 33.87% | 4,636,188 | 1.58 | |
| ≡ | Vulcan Value Partners | Reduce 67.13% | 298,224 | 1.02 | |
| ≡ | Samantha McLemore - Patient Capital Management | Reduce 92.44% | 122,828 | 1.22 | |
| ≡ | Sarah Ketterer - Causeway Capital Management | Sell 100.00% | 292,231 | 1.33 | |
| Q3  2024 | |||||
| ≡ | Ariel Investments | Reduce 2.18% | 101 | 0.00 | |
| ≡ | David Katz - Matrix Asset Advisors | Reduce 3.06% | 1,137 | 0.02 | |
| ≡ | Dodge & Cox Funds | Reduce 4.79% | 1,647,611 | 0.17 | |
| ≡ | John Armitage - Egerton Capital | Reduce 5.78% | 158,255 | 0.29 | |
| ≡ | Bill Nygren - Oakmark Funds | Reduce 7.45% | 1,102,003 | 0.33 | |
| ≡ | Vulcan Value Partners | Reduce 26.00% | 156,086 | 0.47 | |
| ≡ | Samantha McLemore - Patient Capital Management | Reduce 30.68% | 58,820 | 0.52 | |
| ≡ | Sarah Ketterer - Causeway Capital Management | Reduce 32.19% | 138,723 | 0.63 | |
| ≡ | ValueAct Capital | Sell 100.00% | 1,103,759 | 4.63 | |
| ≡ | Mason Hawkins - Southeastern Asset Management | Sell 100.00% | 211,917 | 1.38 | |
| Q2  2024 | |||||
| ≡ | Torray Funds | Reduce 0.07% | 110 | 0.00 | |
| ≡ | Dodge & Cox Funds | Reduce 0.69% | 238,631 | 0.02 | |
| ≡ | Mairs & Power Funds | Reduce 0.91% | 17,414 | 0.03 | |
| ≡ | David Katz - Matrix Asset Advisors | Reduce 1.83% | 690 | 0.01 | |
| ≡ | Mason Hawkins - Southeastern Asset Management | Reduce 6.57% | 14,893 | 0.10 | |
| ≡ | Vulcan Value Partners | Reduce 7.33% | 47,462 | 0.11 | |
| ≡ | Samantha McLemore - Patient Capital Management | Reduce 17.89% | 41,755 | 0.33 | |
| ≡ | John Armitage - Egerton Capital | Reduce 19.32% | 655,536 | 0.99 | |
| ≡ | ValueAct Capital | Reduce 69.81% | 2,551,882 | 10.70 | |
| Q1  2024 | |||||
| ≡ | Torray Funds | Reduce 0.61% | 927 | 0.02 | |
| ≡ | John Armitage - Egerton Capital | Reduce 1.62% | 56,007 | 0.09 | |
| ≡ | Samantha McLemore - Patient Capital Management | Reduce 9.05% | 23,234 | 0.18 | |
| ≡ | ValueAct Capital | Reduce 12.73% | 533,200 | 1.88 | |
| ≡ | Sarah Ketterer - Causeway Capital Management | Reduce 21.38% | 115,450 | 0.50 | |
| ≡ | David Katz - Matrix Asset Advisors | Reduce 49.97% | 37,751 | 0.72 | |
| Q4  2023 | |||||
| ≡ | John Armitage - Egerton Capital | Reduce 2.57% | 91,085 | 0.13 | |
| ≡ | Samantha McLemore - Patient Capital Management | Reduce 5.15% | 13,947 | 0.10 | |
| ≡ | David Katz - Matrix Asset Advisors | Reduce 7.24% | 5,894 | 0.10 | |
| ≡ | Sarah Ketterer - Causeway Capital Management | Reduce 18.57% | 123,180 | 0.44 | |
| ≡ | ValueAct Capital | Reduce 44.51% | 3,360,000 | 8.94 | |
| ≡ | Lee Ainslie - Maverick Capital | Sell 100.00% | 5,087 | 0.01 | |
| Q3  2023 | |||||
| ≡ | David Katz - Matrix Asset Advisors | Reduce 0.92% | 760 | 0.01 | |
| ≡ | Torray Funds | Reduce 1.40% | 2,158 | 0.04 | |
| ≡ | Samantha McLemore - Patient Capital Management | Reduce 6.55% | 18,983 | 0.13 | |
| ≡ | ValueAct Capital | Reduce 35.19% | 4,098,935 | 10.40 | |
| ≡ | Lee Ainslie - Maverick Capital | Reduce 38.38% | 3,169 | 0.01 | |
| Q2  2023 | |||||
| ≡ | Torray Funds | Reduce 0.56% | 860 | 0.02 | |
| ≡ | David Katz - Matrix Asset Advisors | Reduce 1.93% | 1,616 | 0.03 | |
| ≡ | John Armitage - Egerton Capital | Reduce 3.38% | 118,355 | 0.15 | |
| ≡ | Sarah Ketterer - Causeway Capital Management | Reduce 4.93% | 33,825 | 0.12 | |
| ≡ | Bill Miller - Miller Value Partners | Sell 100.00% | 287,648 | 2.03 | |
| ≡ | Seth Klarman - Baupost Group | Sell 100.00% | 533,382 | 1.08 | |
| Q1  2023 | |||||
| ≡ | Torray Funds | Reduce 0.14% | 215 | 0.00 | |
| ≡ | David Katz - Matrix Asset Advisors | Reduce 5.24% | 4,632 | 0.08 | |
| ≡ | Samantha McLemore - Patient Capital Management | Reduce 18.93% | 12,475 | 0.63 | |
| ≡ | ValueAct Capital | Reduce 20.48% | 3,000,000 | 5.52 | |
| ≡ | Bill Miller - Miller Value Partners | Reduce 24.80% | 94,842 | 0.67 | |
| ≡ | Seth Klarman - Baupost Group | Reduce 73.36% | 1,469,009 | 2.97 | |
| Q4  2022 | |||||
| ≡ | David Katz - Matrix Asset Advisors | Reduce 2.64% | 2,402 | 0.04 | |
| ≡ | Samantha McLemore - Patient Capital Management | Reduce 11.78% | 8,800 | 0.44 | |
| ≡ | Bill Miller - Miller Value Partners | Reduce 20.94% | 101,302 | 0.66 | |
| ≡ | Seth Klarman - Baupost Group | Reduce 43.31% | 1,530,000 | 2.63 | |
| Q3  2022 | |||||
| ≡ | Samantha McLemore - Patient Capital Management | Reduce 1.97% | 1,500 | 0.07 | |
| ≡ | Bill Miller - Miller Value Partners | Reduce 17.84% | 105,021 | 0.60 | |
| ≡ | Leon Cooperman | Reduce 48.26% | 415,000 | 2.72 | |
| ≡ | Torray Funds | Reduce 71.98% | 143,557 | 2.67 | |
| Q2  2022 | |||||
| ≡ | Torray Funds | Reduce 5.86% | 12,407 | 0.21 | |
| ≡ | Bill Miller - Miller Value Partners | Reduce 6.43% | 40,468 | 0.20 | |
| ≡ | Seth Klarman - Baupost Group | Reduce 11.43% | 456,000 | 0.62 | |
| ≡ | Leon Cooperman | Reduce 16.55% | 170,600 | 1.04 | |
| ≡ | David Katz - Matrix Asset Advisors | Reduce 28.32% | 34,815 | 0.47 | |
| Q4  2021 | |||||
| ≡ | Torray Funds | Reduce 0.36% | 734 | 0.01 | |
| ≡ | Harry Burn - Sound Shore | Sell 100.00% | 340,300 | 3.02 | |
| Q4  2020 | |||||
| ≡ | Torray Funds | Reduce 4.50% | 2,660 | 0.05 | |
| ≡ | John Armitage - Egerton Capital | Sell 100.00% | 2,190,709 | 1.39 | |
| Q3  2020 | |||||
| ≡ | John Armitage - Egerton Capital | Reduce 42.38% | 1,610,959 | 1.02 | |
| ≡ | Lee Ainslie - Maverick Capital | Sell 100.00% | 9,382 | 0.02 | |
| Q2  2020 | |||||
| ≡ | John Armitage - Egerton Capital | Reduce 41.48% | 2,694,178 | 1.96 | |
| Q1  2020 | |||||
| ≡ | John Armitage - Egerton Capital | Reduce 15.79% | 1,218,237 | 1.20 | |
* "Hold Price" is the last known price at which an investor still held a security. It is the closing price of the security as of the portfolio date (quarter end). This value is only provided when a security is owned by at least two investors. In the case of reporting dates being different, a weighted average price is calculated.